...
首页> 外文期刊>Journal of addiction medicine >Addressing Stigma in Medication Treatment of Adolescents With Opioid Use Disorder
【24h】

Addressing Stigma in Medication Treatment of Adolescents With Opioid Use Disorder

机译:用阿片类药物治疗青少年治疗青少年的耻辱

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In September 2016, the American Academic of Pediatrics released a policy statement that adolescents with opioid use disorder should be offered pharmacotherapy with buprenorphine/naloxone, methadone, or naltrexone. In our clinical practice, however, we have encountered the perception among patients, families, and clinicians alike that medications should be used as a last resort. That we should wait until things get worse is a discarded approach. As addiction specialists, it is imperative that we prevent and identify risky use and use disorders, then intervene early and offer timely, evidence-based treatment. We suggest that adolescents deserve special attention and that specific efforts should be made to reduce the stigma associated with treating adolescents with opioid use disorder with medications to optimize those efforts.
机译:2016年9月,美国儿科学院发布了一项政策声明,即具有阿片类药物使用障碍的青少年应与Buprenorphine / Naloxone,美沙酮或纳罗酮的药物治疗。 然而,在我们的临床实践中,我们遇到了患者,家庭和临床医生的看法,因为这些药物应该被用作最后的手段。 我们应该等到事情变得更糟,是一种丢弃的方法。 作为成瘾专家,我们必须预防和识别危险使用和使用障碍,然后介入早期,并及时介绍基于证据的治疗。 我们建议青少年值得特别注意,并且应该具体努力减少与用药物治疗的青少年治疗青少年,以优化这些努力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号